case_images: PMC10901063_01
case_images: At baseline, large and multiple erythematous plaques covered by coalescent pustules are observed on the back (a) and on the limbs (b).
case_images: 10.1177_2050313X241235451-fig1.jpg
case_images: PMC10901063_01_10.1177_2050313X241235451-fig1.jpg
case_images: fig1-2050313X241235451
case_images: The Generalized Pustular Psoriasis Physician Global Assessment   (GPPGA) was 3.5; the Generalized Pustular Psoriasis Area and Severity Index   (GPPASI) was 32.6; and the Dermatology Life and Quality Index (DLQI) was 30 (Figure 1(a) and (b)).
case_images: At 2 weeks after the first spesolimab dose, complete clearance of the erythematous plaques and pustules on the back (a) and on the limbs (b); some post-inflammatory sequelae persist.
case_images: 10.1177_2050313X241235451-fig2.jpg
case_images: PMC10901063_01_10.1177_2050313X241235451-fig2.jpg
case_images: fig2-2050313X241235451
case_images: NRS = 1/10) (Figure 2(a) and (b)). No adverse events were reported during or after the infusions.